Spontaneous aortocaval fistula is a rare but documented complication of arteriosclerotic abdominal aortic aneurysm. Most cases reported have presented clinically with a palpable aneurysm, abdominal bruit, and high output congestive heart failure. A diagnosis in such cases requires active demonstration of findings secondary to arteriovenous shunting, which can be optimized utilizing proper CT bolus technique and dynamic scanning. We describe several CT findings--all of which may be typical for and support the diagnosis of this potentially lethal complication of abdominal aortic aneurysm.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0895-6111(92)90125-s | DOI Listing |
Vasc Specialist Int
December 2024
Department of Vascular and Endovascular Surgery, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Aortocaval fistulas, typically linked to aortoiliac aneurysms, are rare vascular conditions. Currently, endovascular therapy is preferred treatment approach. However, endovascular therapy requires frequent and extended follow-up evaluations.
View Article and Find Full Text PDFJ Endovasc Ther
November 2024
Department of Interventional Radiology, University Hospital Leuven, Leuven, Belgium.
Purpose: We described an alternative access for thoracic endovascular aortic repair (TEVAR) deployment using a transjugular intrahepatic portosystemic shunt (TIPS) needle for gaining transcaval access to the abdominal aorta.
Case Report: A 63-year-old man presented with a penetrating atherosclerotic ulcer in the descending aorta. Traditional transfemoral and transaxillary access were not possible.
Vasc Endovascular Surg
November 2024
Department of Surgery, SUNY Upstate Medical University, Syracuse, NY, USA.
Primary aortocaval fistulas (ACF) are a rare complication of abdominal aortic aneurysm (AAA), for which treatment options encompass both endovascular and open surgical intervention. To report a rare presentation of primary aortocaval fistula. Case Report.
View Article and Find Full Text PDFArterioscler Thromb Vasc Biol
December 2024
Vascular Biology and Therapeutics Program (W.Z., L.G., H.B., Z.L., R.T., J.L., Y.O., C.T., A.Y., B.Y., K.A.M., J.G., G.T., A.D.), Yale School of Medicine, New Haven, CT.
Background: Arteriovenous fistulae (AVF) are the preferred vascular access for hemodialysis in patients with end-stage kidney disease. Chronic kidney disease (CKD) is associated with endothelial injury, impaired AVF maturation, and reduced patency, as well as utilization. Because CKD is characterized by multiple pathophysiological processes that induce endothelial-to-mesenchymal transition (EndMT), we hypothesized that CKD promotes EndMT during venous remodeling and that disruption of endothelial TGF (transforming growth factor)-β signaling inhibits EndMT to prevent AVF failure even in the end-stage kidney disease environment.
View Article and Find Full Text PDFInt Angiol
August 2024
Clinic for Vascular and Endovascular Surgery, University Clinical Center of Serbia, Belgrade, Serbia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!